Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma

被引：4
作者：
Ku, Geoffrey [1 ]
Ilson, David [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10065 USA
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 05期
关键词：
CANCER; TRIAL; CHEMORADIOTHERAPY; ESOPHAGEAL; SURGERY;
D O I：
10.1016/S1470-2045(17)30280-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E243 / E243
页数：1
相关论文
共 7 条
  • [1] Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)
    Alderson, Derek
    Langley, Ruth E.
    Nankivell, Matthew Guy
    Blazeby, Jane M.
    Griffin, Michael
    Crellin, Adrian
    Grabsch, Heike I.
    Okines, Alicia Frances Clare
    Goldstein, Cindy
    Falk, Stephen
    Thompson, Joyce
    Krysztopik, Richard
    Coxon, Fareeda Y.
    Pritchard, Susan
    Langer, Rupert
    Stenning, Sally Patricia
    Cunningham, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] [Anonymous], NATURE
  • [3] Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
    Burmeister, BH
    Smithers, BM
    Gebski, V
    Fitzgerald, L
    Simes, RJ
    Devitt, P
    Ackland, S
    Gotley, DC
    Joseph, D
    Millar, J
    North, J
    Walpole, ET
    Denham, JW
    [J]. LANCET ONCOLOGY, 2005, 6 (09) : 659 - 668
  • [4] Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial
    Cunningham, David
    Stenning, Sally P.
    Smyth, Elizabeth C.
    Okines, Alicia F.
    Allum, William H.
    Rowley, Sam
    Stevenson, Laura
    Grabsch, Heike I.
    Alderson, Derek
    Crosby, Thomas
    Griffin, S. Michael
    Mansoor, Wasat
    Coxon, Fareeda Y.
    Falk, Stephen J.
    Darby, Suzanne
    Sumpter, Kate A.
    Blazeby, Jane M.
    Langley, Ruth E.
    [J]. LANCET ONCOLOGY, 2017, 18 (03) : 357 - 370
  • [5] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham, David
    Allum, William H.
    Stenning, Sally P.
    Thompson, Jeremy N.
    Van de Velde, Cornelis J. H.
    Nicolson, Marianne
    Scarffe, J. Howard
    Lofts, Fiona J.
    Falk, Stephen J.
    Iveson, Timothy J.
    Smith, David B.
    Langley, Ruth E.
    Verma, Monica
    Weeden, Simon
    Chua, Yu Jo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) : 11 - 20
  • [6] HLA-B N L., 2017, Nature, V543, P16
  • [7] Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
    van Hagen, P.
    Hulshof, M. C. C. M.
    van Lanschot, J. J. B.
    Steyerberg, E. W.
    Henegouwen, M. I. van Berge
    Wijnhoven, B. P. L.
    Richel, D. J.
    Nieuwenhuijzen, G. A. P.
    Hospers, G. A. P.
    Bonenkamp, J. J.
    Cuesta, M. A.
    Blaisse, R. J. B.
    Busch, O. R. C.
    ten Kate, F. J. W.
    Creemers, G. -J.
    Punt, C. J. A.
    Plukker, J. T. M.
    Verheul, H. M. W.
    Bilgen, E. J. Spillenaar
    van Dekken, H.
    van der Sangen, M. J. C.
    Rozema, T.
    Biermann, K.
    Beukema, J. C.
    Piet, A. H. M.
    van Rij, C. M.
    Reinders, J. G.
    Tilanus, H. W.
    van der Gaast, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) : 2074 - 2084
1